EPHX2 antibody

Catalogue No.:FNab02811Reactivity:Human
Host:RabbitTested Application:ELISA, WB, IHC, IP
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
EPHX2 antibody
Catalogue No.
FNab02811
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
epoxide hydrolase 2, cytoplasmic
UniProt ID
P34913
Observed MW
63 kDa
Application
Tested Applications
ELISA, WB, IHC, IP
Recommended dilution
WB: 1:500-1:2000; IP: 1:200-1:1000; IHC: 1:20-1:200
Validated Images
HeLa cells were subjected to SDS PAGE followed by western blot with FNab02811(EPHX2 antibody) at dilution of 1:1000
IP result of anti-EPHX2(IP:FNab02811, 4ug; Detection:FNab02811 1:300) with mouse large intestine tissue lysate 3200 ug
Immunohistochemistry of paraffin-embedded human colon cancer using FNab02811(EPHX2 antibody) at dilution of 1:100
Background
Bifunctional enzyme. The C-terminal domain has epoxide hydrolase activity and acts on epoxides(alkene oxides, oxiranes) and arene oxides. Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. Also determines steady-state levels of physiological mediators. The N-terminal domain has lipid phosphatase activity, with the highest activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid, 12-phosphonooxy-octadec-9E-enoic acid, and p-nitrophenyl phospate.